Cargando…
A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis
We investigated the prognostic value of a range of histologic parameters in medullary thyroid carcinoma (MTC) to design a grading system to predict overall survival. We assessed 76 patients with MTCs undergoing primary tumor resection for age, sex, tumor size, vascular space invasion, lymph node met...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641183/ https://www.ncbi.nlm.nih.gov/pubmed/32452872 http://dx.doi.org/10.1097/PAS.0000000000001505 |
_version_ | 1783605875844317184 |
---|---|
author | Fuchs, Talia L. Nassour, Anthony J. Glover, Anthony Sywak, Mark S. Sidhu, Stan B. Delbridge, Leigh W. Clifton-Bligh, Roderick J. Gild, Matti L. Tsang, Venessa Robinson, Bruce G. Clarkson, Adele Sheen, Amy Sioson, Loretta Chou, Angela Gill, Anthony J. |
author_facet | Fuchs, Talia L. Nassour, Anthony J. Glover, Anthony Sywak, Mark S. Sidhu, Stan B. Delbridge, Leigh W. Clifton-Bligh, Roderick J. Gild, Matti L. Tsang, Venessa Robinson, Bruce G. Clarkson, Adele Sheen, Amy Sioson, Loretta Chou, Angela Gill, Anthony J. |
author_sort | Fuchs, Talia L. |
collection | PubMed |
description | We investigated the prognostic value of a range of histologic parameters in medullary thyroid carcinoma (MTC) to design a grading system to predict overall survival. We assessed 76 patients with MTCs undergoing primary tumor resection for age, sex, tumor size, vascular space invasion, lymph node metastasis, multiple endocrine neoplasia type 2 (MEN2) status, mitotic count, Ki-67 proliferative index, spindled morphology, sheet-like growth pattern, coagulative necrosis, incipient necrosis, nuclear grade, multinucleation, prominent nucleoli, fibrosis, and amyloid deposition. In addition to the clinical features of age and the diagnosis of MEN2, the only histologic features that significantly predicted reduced overall survival were Ki-67 proliferative index, mitotic count, and the presence of coagulative necrosis. Using a combination of these 3 variables, we propose a 3-tiered grading system based solely on proliferative activity (Ki-67 proliferative index and mitotic count) and necrosis. There were 62 (82%) low-grade MTCs (low proliferative activity, no necrosis), 9 (12%) intermediate grade (low proliferative activity and necrosis present, or intermediate proliferative activity and no necrosis), and 5 (7%) high grade (intermediate proliferative activity and necrosis present, or high proliferative activity with or without necrosis). The mean overall survival was 193, 146, and 45 months, respectively (P=0.0001) for the 3 grades. The grading system remained prognostic when controlled for other factors associated with survival including age and known MEN2 syndrome. We conclude that this proposed grading system, which uses only a combination of proliferative activity (Ki-67 index, mitotic count) and coagulative necrosis, is a strong predictor of overall survival in MTC. |
format | Online Article Text |
id | pubmed-7641183 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-76411832020-11-12 A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis Fuchs, Talia L. Nassour, Anthony J. Glover, Anthony Sywak, Mark S. Sidhu, Stan B. Delbridge, Leigh W. Clifton-Bligh, Roderick J. Gild, Matti L. Tsang, Venessa Robinson, Bruce G. Clarkson, Adele Sheen, Amy Sioson, Loretta Chou, Angela Gill, Anthony J. Am J Surg Pathol Original Articles We investigated the prognostic value of a range of histologic parameters in medullary thyroid carcinoma (MTC) to design a grading system to predict overall survival. We assessed 76 patients with MTCs undergoing primary tumor resection for age, sex, tumor size, vascular space invasion, lymph node metastasis, multiple endocrine neoplasia type 2 (MEN2) status, mitotic count, Ki-67 proliferative index, spindled morphology, sheet-like growth pattern, coagulative necrosis, incipient necrosis, nuclear grade, multinucleation, prominent nucleoli, fibrosis, and amyloid deposition. In addition to the clinical features of age and the diagnosis of MEN2, the only histologic features that significantly predicted reduced overall survival were Ki-67 proliferative index, mitotic count, and the presence of coagulative necrosis. Using a combination of these 3 variables, we propose a 3-tiered grading system based solely on proliferative activity (Ki-67 proliferative index and mitotic count) and necrosis. There were 62 (82%) low-grade MTCs (low proliferative activity, no necrosis), 9 (12%) intermediate grade (low proliferative activity and necrosis present, or intermediate proliferative activity and no necrosis), and 5 (7%) high grade (intermediate proliferative activity and necrosis present, or high proliferative activity with or without necrosis). The mean overall survival was 193, 146, and 45 months, respectively (P=0.0001) for the 3 grades. The grading system remained prognostic when controlled for other factors associated with survival including age and known MEN2 syndrome. We conclude that this proposed grading system, which uses only a combination of proliferative activity (Ki-67 index, mitotic count) and coagulative necrosis, is a strong predictor of overall survival in MTC. Lippincott Williams & Wilkins 2020-10 2020-05-22 /pmc/articles/PMC7641183/ /pubmed/32452872 http://dx.doi.org/10.1097/PAS.0000000000001505 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Original Articles Fuchs, Talia L. Nassour, Anthony J. Glover, Anthony Sywak, Mark S. Sidhu, Stan B. Delbridge, Leigh W. Clifton-Bligh, Roderick J. Gild, Matti L. Tsang, Venessa Robinson, Bruce G. Clarkson, Adele Sheen, Amy Sioson, Loretta Chou, Angela Gill, Anthony J. A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis |
title | A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis |
title_full | A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis |
title_fullStr | A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis |
title_full_unstemmed | A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis |
title_short | A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis |
title_sort | proposed grading scheme for medullary thyroid carcinoma based on proliferative activity (ki-67 and mitotic count) and coagulative necrosis |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641183/ https://www.ncbi.nlm.nih.gov/pubmed/32452872 http://dx.doi.org/10.1097/PAS.0000000000001505 |
work_keys_str_mv | AT fuchstalial aproposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT nassouranthonyj aproposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT gloveranthony aproposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT sywakmarks aproposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT sidhustanb aproposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT delbridgeleighw aproposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT cliftonblighroderickj aproposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT gildmattil aproposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT tsangvenessa aproposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT robinsonbruceg aproposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT clarksonadele aproposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT sheenamy aproposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT siosonloretta aproposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT chouangela aproposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT gillanthonyj aproposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT fuchstalial proposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT nassouranthonyj proposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT gloveranthony proposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT sywakmarks proposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT sidhustanb proposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT delbridgeleighw proposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT cliftonblighroderickj proposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT gildmattil proposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT tsangvenessa proposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT robinsonbruceg proposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT clarksonadele proposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT sheenamy proposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT siosonloretta proposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT chouangela proposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis AT gillanthonyj proposedgradingschemeformedullarythyroidcarcinomabasedonproliferativeactivityki67andmitoticcountandcoagulativenecrosis |